Zacks: Analysts Anticipate Masimo Co. (MASI) Will Post Earnings of $0.73 Per Share

Equities analysts expect Masimo Co. (NASDAQ:MASI) to announce $0.73 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Masimo’s earnings, with the lowest EPS estimate coming in at $0.70 and the highest estimate coming in at $0.76. Masimo posted earnings per share of $0.83 in the same quarter last year, which would suggest a negative year over year growth rate of 12%. The business is scheduled to announce its next earnings results on Wednesday, August 1st.

On average, analysts expect that Masimo will report full-year earnings of $2.88 per share for the current financial year. For the next year, analysts anticipate that the company will report earnings of $2.98 per share, with EPS estimates ranging from $2.92 to $3.03. Zacks’ EPS calculations are a mean average based on a survey of research analysts that that provide coverage for Masimo.

Get Masimo alerts:

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, May 2nd. The medical equipment provider reported $0.75 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.06. The firm had revenue of $212.90 million for the quarter, compared to analyst estimates of $205.65 million. Masimo had a net margin of 15.99% and a return on equity of 23.14%. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.57 earnings per share.

MASI has been the subject of a number of research reports. Zacks Investment Research downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Monday, March 5th. ValuEngine upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research report on Monday, May 7th. Barclays initiated coverage on shares of Masimo in a research report on Friday, March 9th. They set an “overweight” rating and a $97.00 target price for the company. Piper Jaffray Companies restated a “hold” rating and set a $91.00 target price on shares of Masimo in a research report on Thursday, March 1st. Finally, BidaskClub upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research report on Tuesday, April 24th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Masimo presently has a consensus rating of “Buy” and a consensus price target of $101.17.

Shares of MASI traded up $0.14 during trading hours on Wednesday, reaching $99.12. 193,699 shares of the company traded hands, compared to its average volume of 497,507. The firm has a market capitalization of $5.13 billion, a PE ratio of 40.46, a price-to-earnings-growth ratio of 2.37 and a beta of 0.95. Masimo has a 12-month low of $80.69 and a 12-month high of $100.00.

In related news, CAO Ramshorst David J. Van sold 3,000 shares of the business’s stock in a transaction on Friday, May 4th. The shares were sold at an average price of $97.50, for a total transaction of $292,500.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,500 shares in the company, valued at $243,750. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Sanford Fitch sold 2,000 shares of the business’s stock in a transaction on Thursday, May 3rd. The shares were sold at an average price of $94.00, for a total transaction of $188,000.00. Following the transaction, the director now owns 62,249 shares of the company’s stock, valued at $5,851,406. The disclosure for this sale can be found here. Insiders have sold 122,303 shares of company stock valued at $11,148,690 over the last 90 days. 12.60% of the stock is currently owned by insiders.

Several institutional investors have recently modified their holdings of the business. Intrust Bank NA raised its position in shares of Masimo by 15.5% in the first quarter. Intrust Bank NA now owns 4,490 shares of the medical equipment provider’s stock worth $395,000 after acquiring an additional 603 shares during the period. Ladenburg Thalmann Financial Services Inc. raised its position in shares of Masimo by 7.4% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 10,368 shares of the medical equipment provider’s stock worth $879,000 after acquiring an additional 718 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Masimo by 39.7% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,820 shares of the medical equipment provider’s stock worth $239,000 after acquiring an additional 802 shares during the period. Brown Capital Management LLC raised its position in shares of Masimo by 0.8% in the fourth quarter. Brown Capital Management LLC now owns 98,506 shares of the medical equipment provider’s stock worth $8,353,000 after acquiring an additional 819 shares during the period. Finally, Eagle Asset Management Inc. raised its position in shares of Masimo by 2.8% in the fourth quarter. Eagle Asset Management Inc. now owns 33,704 shares of the medical equipment provider’s stock worth $2,858,000 after acquiring an additional 932 shares during the period. Institutional investors and hedge funds own 82.92% of the company’s stock.

Masimo Company Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Get a free copy of the Zacks research report on Masimo (MASI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

3 Stocks That Could Put Alibaba's Returns to Shame

Jack Ma, Peng Lei, and a team of sixteen other partners co-founded Alibaba�(NYSE:BABA) in 1999 and would go on to shape and dominate China's online retail market in the years that followed. The company was eventually taken public in September 2014, setting a record for the world's largest ever initial public offering (IPO) with a roughly $230 billion valuation for the company at market close. Today, Alibaba has a market capitalization of roughly $500 billion, and the strength of its online-retail network, momentum in Chinese e-commerce, and expansion into high-reward categories like artificial intelligence suggest that the company still has numerous avenues to growth.

That said,�there are other, even more promising stocks for investors seeking big returns, and we've asked three of our Motley Fool investors to identify a company that has what it takes to outperform Alibaba down the stretch. Read on to see why they picked Vertex Pharmaceuticals (NASDAQ:VRTX), Tencent Holdings (NASDAQOTH:TCEHY), and Baozun (NASDAQ:BZUN)�as superior growth vehicles.

Image source: Getty Images.

One of Alibaba's e-commerce partners

Keith Noonan�(Baozun):�Many of the same tailwinds poised to benefit Alibaba should also benefit Baozun -- an e-commerce company that specializes in providing online sales platforms for consumer brands including Nike, Microsoft, and Calvin Klein in the Chinese market.�

Baozun is partnered with Tmall -- China's most popular online-retail platform and the core of Alibaba's business. Baozun-powered online stores are featured on Tmall, and Alibaba also owns a roughly 16% stake in its smaller e-commerce partner. However, Jack Ma's company isn't Baozun's only partner. With presence on JD.com's and Tencent Holdings' platforms as well, Baozun stores enjoy wide integration across the Chinese e-commerce space.

Valued at roughly $3 billion, Baozun is a small company compared to China's online retail titans, but it already has a broad imprint in the market and a promising opportunity to be a part of the growth that's happening there. Things have been looking pretty good on that front.

Sales were up 14.5% year over year in Baozun's March-ended quarter -- the company's lowest quarterly sales growth since 2014 but a laudable result when placed in context. Net income for the period climbed 41% as the company continued the early stages of a pivot away from storing and shipping orders and toward the more profitable service of providing online sales platforms and connecting brands with customers.

Promising early results for the transition and the potential to continue increasing its brand-partner count and customer sales base explain why the stock is up roughly 145% over the last year, and I think the long-term outlook holds even more promise. Alibaba still has plenty of opportunity for growth, but I wouldn't be at all surprised to see Baozun stock outperform it over the next decade.

Take advantage of this temporary monopoly

Keith Speights�(Vertex Pharmaceuticals): The great thing about biotechs that focus on rare diseases is that they can enjoy a monopoly after winning FDA approval for their drugs -- at least for a while. That's exactly the situation for Vertex Pharmaceuticals.

Vertex claims three approved drugs that treat cystic fibrosis (CF) by helping ensure that CFTR proteins are produced correctly instead of being misfolded. These drugs -- Kalydeco, Orkambi, and Symdeko -- are called CFTR modulators. How many other CFTR modulators are on the market right now? Zero.

But Vertex's currently approved drugs can only treat around 44,000 CF patients. There are an estimated 75,000 CF patients worldwide. That presents a significant opportunity for the company to grow. Vertex is developing several triple-drug combination therapies that should enable it to treat another 24,000 CF patients. The biotech is also researching use of gene editing to help the remaining CF patients.�

Another biotech, Galapagos,�is also developing triple-drug combos for CF. However, Vertex has a solid head start. And its first-mover advantage should be significant.

In addition to CF, Vertex is targeting several other indications, including rare genetic blood disorders beta-thalassemia and sickle cell disease. These programs are still several years away from potentially reaching the market. However, Vertex has several shots on goal and definitely has a proven track record of success with its clinical development efforts.

Alibaba is a great stock, but I have personally only bought one stock over the past couple of months -- Vertex. I think it will be a big winner over the long run.

Video games, social media, and cloud computing... oh my

Nicholas Rossolillo�(Tencent Holdings):�Video game and social media operator Tencent sits near the top of the list of China's largest public corporations. Its stock has also doubled in the last year and a half, putting it on par with Alibaba's returns. However, big gains could still be in store for this internet giant.

Investors got worried early in the year that profits would shrink as Tencent used cash flow from its global video game empire and leading Chinese social platforms QQ and WeChat to invest in newer business like online payment solutions and cloud computing services. During the first quarter of 2018, some of those worries were laid to rest. Revenue and operating profit rose 48% and 59%, respectively. As to the latter metric, the operating profit margin improved to 42% from 39% a year ago and at the end of 2017.

Even though Tencent is already a huge company -- currently carrying a market cap of $495 billion -- that shouldn't scare growth investors away. Tencent is only just beginning to monetize its social media business through advertising, with sales from that department growing 69% from the same period a year ago. Other segments like cloud and payments more than doubled in size and now make up nearly a quarter of all revenue. With that kind of momentum, Tencent's stock could be headed much higher.

Macy's Stock Upgraded: What You Need to Know

Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it under the microscope...

Macy's (NYSE:M) stock popped more than 10% last week after reporting earnings that "beat analyst estimates on all accounts" -- and that may be only the beginning.

Since scoring its 11% gain after earnings last Wednesday, Macy's stock has marched steadily higher as investors took time to digest the results. This task completed, analysts at Susquehanna Financial announced�this morning they're upgrading it to positive and assigning a $43 price target to this $35 stock.

Here's why.

Image source: Macy's.

What Macy's said

Macy's released earnings�on Tuesday evening last week. Sales rose only 3.6%, but that was still much better than what analysts had been expecting Macy's to report, and same-store sales among stores Macy's owns did even better -- up 3.9%.

All told, Macy's moved $5.54 billion worth of merchandise in the first quarter of 2018 and earned $0.45 per share. Gross margin at the retailer expanded by 70 basis points to 39%, while operating profit margin gained 20 basis points, rising to 4.3%. Profits on the bottom line -- $131 million net of all costs -- increased 70% year over year and gave Macy's a 2.4% net profit margin for the quarter. Macy's credited its ability to maintain a "healthy inventory position" for keeping discounts in check and profit margins high.

CEO Jeff Gennette noted that these results "exceeded our expectations," with Macy's showing strength in "all three brands -- Macy's, Bloomingdale's, and Bluemercury -- as well as across all geographic regions and families of business."

What Macy's predicted

And that good performance could get even better. Gennette promised investors "we have more work to do" in quarters to come. Still, based on how well things are progressing so far, the CEO felt confident enough to raise guidance for both sales and earnings for the rest of this year.

Macy's now expects to earn adjusted�earnings per diluted share of $3.75 to $3.95 in fiscal 2018. Granted, this number excludes "anticipated settlement charges related to the company's defined benefit plans as well as impairment and other costs." But even so, Macy's adjusted earnings in Q1 weren't that far off from what it was able to report using more stringent GAAP accounting measures (only $0.03 per share less), so the final GAAP figure should still look pretty good.

What Susquehanna had to say about that

All in all, Susquehanna considered Macy's to have turned in a fine report. The banker cited the company's positive same-store sales figures and its "unexpected strong operating" margins as being of particular note, according to a write-up today on StreetInsider.com�(subscription required).

What really seems to get this analyst's attention, though, is the valuation of Macy's stock. As Susquehanna argues, Macy shares "trade at 9.0x current-year�earnings." (Note: The stock actually sells for even cheaper than that when valued on trailing earnings -- just 6.6 times earnings.) However, says the analyst, "historically even department stores trade higher, around 11x-12x, particularly when company operations are showing better momentum, when we have seen 13x earnings."

As investors begin to key in to this fact, Susquehanna predicts Macy's P/E ratio will grow over time. The analyst bases its prediction of $43 a share on an expectation that investors will pay at least 10.5 times Macy's expected next-year earnings of $4.11 a share. But if the analyst's theory is right, it could theoretically sell for as much as 24% more than that. For example, 13 times $4.11 per share would imply a $53 stock price -- and close to a 50% profit for new investors today.�

The upshot for investors

Is that result likely? I have to say that to me, hoping for 50% profits on Macy's stock seems like a stretch. Still, with shares paying a 4.4% dividend yield, and consensus expectations for the company's earnings growth still very conservative (S&P Global Market Intelligence�data suggest Macy's may grow earnings only 1.5% annually over the next five years), the stock offers a respectable 5.9% total return. Worst case, that at least doesn't seem crazy expensive given Macy's 6.9 P/E ratio.

What's more, if Macy's grows anywhere near as fast as Susquehanna seems to think it's capable of -- or even just as fast as it grew last quarter -- the stock really could be a bargain.

Hot Cheap Stocks For 2018

tags:WEN,IBM,EMR,RCII,USG,GD,

My interest in GNC Holdings (NYSE:GNC) stems from an interest in basic cheapness and deep value investments. Below I've highlighted some of the 'cheapness' valuations of GNC at $8.25 (as of March 3, 2017 close).

GNC's current market cap is $564 million and has an enterprise value of $2.7 billion with 68,403,901 shares outstanding. Forward P/E = 4.91 P/FCF = 4.06 TTM highest stock price of $35.90, lowest stock price of $6.95

The merits of a GNC long position are well documented in other Seeking Alpha articles, especially from the spirited writer Courage and Conviction Investing (I have really enjoyed reading his work). Courage and Conviction has written extensively on the potential near- and long-term catalysts of the GNC turnaround model under interim CEO Robert Maran. I've highlighted a few of the bullish investment thesis points below:

Despite growth in online supplement retailers (e.g. Amazon (NASDAQ:AMZN) and bodybuilders.com) and wholesale shops (e.g. Costco (NASDAQ:COST)), GNC continues to be profitable, generating free cash flow. Potential short squeeze if near-term catalysts materialize due to high percentage of short floats. New GNC business model will gain traction and produce incremental same-store comps and increases in revenue by Q3 2017. Indeed, in the most recent earnings call, GNC management said they are seeing 7% growth in transactions from the new GNC model. Insider purchasing - interim CEO Robert Maran purchased nearly $5.4 million worth of GNC stock on the open market late in February. Other insider purchases as well. GNC could be a potential takeover target. On Friday, March 3, 2017, GNC started the day up 8% after rumors of a KKR takeover.

As a contrarian investor, I am drawn to the speculative appeal of the long thesis for GNC. I think many of the bullish GNC Seeking Alpha contributors have done an excellent job articulating the long argument, and I don't have anything truly unique to add to this discussion.

Hot Cheap Stocks For 2018: Wendy's/Arby's Group Inc.(WEN)

Advisors' Opinion:

• [By Shane Hupp]

  Wendy’s (NASDAQ:WEN)‘s stock had its “buy” rating reiterated by equities researchers at Argus in a research note issued to investors on Thursday. They currently have a $16.34 price target on the restaurant operator’s stock, down from their prior price target of $19.00.

• [By Matt Hogan]

  Growth within the industry is a bit lumpy, with limited-service restaurants, such as Wendys Co (NASDAQ: WEN) and Chipotle Mexican Grill, Inc (NYSE: CMG), growing at 5.3 percent in 2017 as compared to 3.5 percent for casual dining establishments according to the National Restaurant Industry.

• [By Logan Wallace]

  Wendy’s (NASDAQ:WEN) major shareholder Edward P. Garden sold 764,000 shares of the business’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $16.53, for a total value of $12,628,920.00. Following the completion of the sale, the insider now directly owns 240,365 shares of the company’s stock, valued at approximately $3,973,233.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

• [By Lisa Levin]

   

  Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

Hot Cheap Stocks For 2018: International Business Machines Corporation(IBM)

Advisors' Opinion:

• [By Paul Ausick]

  The DJIA stock posting the largest daily percentage gain ahead of the close Wednesday was International Business Machines Corp. (NYSE: IBM) which traded up 2.85% at $158.65. The stock’s 52-week range is $139.13 to $182.79. Volume was about 35% above the daily average of around 4.8 million shares. The company’s stock was raised to Outperform at RBC Capital Markets this morning.

• [By Anders Bylund, Leo Sun, and Demitrios Kalogeropoulos]

  IBM (NYSE:IBM) is the market leader in blockchain�technologies, but its core business is filled with legacy operations offsetting the higher growth of its cloud, mobile, analytics, security, and social businesses. As a result, analysts expect IBM's revenue and earnings to only rise about 1% this year.

• [By Michael A. Robinson]

  I confess: I'd always hated IBM Corp. (NYSE: IBM); never could stand Big Blue. The company was always too unfocused for my taste.

  Its boardroom underwhelmed, too, allowing Microsoft Corp. (Nasdaq: MSFT) and Amazon.com Inc. (Nasdaq: AMZN) to outmaneuver and shut it out of the outrageously lucrative cloud.

• [By Michael A. Robinson]

  IBM Corp. (NYSE: IBM) has bet big on blockchain – and the company's leaders see it as vital to its future success.

  That said, IBM remains a poor investment. The company's legacy businesses are slowing down faster than its strategic initiatives are growing. Moreover, its leadership is unfocused and neglectful toward shareholders.

Hot Cheap Stocks For 2018: Emerson Electric Company(EMR)

Advisors' Opinion:

• [By Logan Wallace]

  D.A. Davidson & CO. lifted its position in shares of Emerson Electric (NYSE:EMR) by 1.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 574,584 shares of the industrial products company’s stock after buying an additional 7,640 shares during the period. Emerson Electric makes up about 0.8% of D.A. Davidson & CO.’s holdings, making the stock its 25th biggest holding. D.A. Davidson & CO.’s holdings in Emerson Electric were worth $39,244,000 at the end of the most recent reporting period.

• [By Stephan Byrd]

  Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

  Get Emerson Electric alerts: Stocks This Week: Wells Fargo, Emerson Electric and CSX (finance.yahoo.com) Emerson Electric (EMR) & Philips (PHG) Financial Review (americanbankingnews.com) Emerson Electric (EMR) Given Consensus Rating of “Hold” by Brokerages (americanbankingnews.com) Is It Time To Buy Emerson Electric Co (NYSE:EMR)? (finance.yahoo.com) Emerson Electric: An Autonomous Future (seekingalpha.com)

  EMR has been the topic of a number of research reports. Zacks Investment Research raised shares of Emerson Electric from a “hold” rating to a “buy” rating and set a $78.00 price objective on the stock in a research note on Thursday, February 8th. UBS initiated coverage on shares of Emerson Electric in a research note on Monday, January 22nd. They issued a “buy” rating and a $73.26 price objective on the stock. Cowen reissued a “buy” rating and issued a $78.00 price objective on shares of Emerson Electric in a research note on Wednesday, April 18th. Stifel Nicolaus increased their price objective on shares of Emerson Electric from $79.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, May 3rd. Finally, Berenberg Bank raised shares of Emerson Electric from a “sell” rating to a “hold” rating and set a $69.00 price objective on the stock in a research note on Tuesday, April 24th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the stock. Emerson Electric has a consensus rating of “Hold” and a consensus price target of $73.00.

• [By Max Byerly]

  Flippin Bruce & Porter Inc. decreased its holdings in Emerson Electric (NYSE:EMR) by 33.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,251 shares of the industrial products company’s stock after selling 33,574 shares during the quarter. Flippin Bruce & Porter Inc.’s holdings in Emerson Electric were worth $4,525,000 as of its most recent filing with the Securities & Exchange Commission.

Hot Cheap Stocks For 2018: Rent-A-Center Inc.(RCII)

Advisors' Opinion:

• [By ]

  Engaged Capital maintained large positions in Rent-A-Center (RCII) , TiVo (TIVO) , Hain Celestial (HAIN) , SunOpta and Jamba Inc. (JMBA) , all companies that have either previously been targeted by Welling or currently are in his cross-hairs.

• [By Max Byerly]

  COPYRIGHT VIOLATION NOTICE: “Q1 2018 EPS Estimates for Rent-A-Center Increased by KeyCorp (RCII)” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/3350595/q1-2018-eps-estimates-for-rent-a-center-increased-by-keycorp-rcii.html.

• [By Ethan Ryder]

  Rent-A-Center (NASDAQ:RCII) gapped down before the market opened on Wednesday . The stock had previously closed at $9.36, but opened at $9.43. Rent-A-Center shares last traded at $9.54, with a volume of 375675 shares changing hands.

• [By Logan Wallace]

  AerCap (NYSE: AER) and Rent-A-Center (NASDAQ:RCII) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation.

Hot Cheap Stocks For 2018: USG Corporation(USG)

Advisors' Opinion:

• [By Stephan Byrd]

  ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

  A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

• [By Jordan Wathen]

  As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG's board members who are up for re-election at this year's annual meeting, a clear message that Buffett is ready to cash in, even if USG's management and board are not.

• [By Dan Caplinger]

  Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett's involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

Hot Cheap Stocks For 2018: S&P GSCI(GD)

Advisors' Opinion:

• [By Chris Dier-Scalise]

  What gives? Well, all of the top six holdings in the fund—Boeing Co (NYSE: BA), United Technologies Corporation (NYSE: UTX), Lockheed Martin Corporation (NYSE: LMT), General Dynamics Corporation (NYSE: GD), Raytheon Company (NYSE: RTN), and Northrup Grumman Corporation (NYSE: NOC)—all either met or exceeded Q4 earnings estimates. Together, those six companies make up about 45 percent of the fund.

• [By ]

  Moreno was also upbeat on General Dynamics (GD) , which just made a bullish crossover, but felt that Raytheon had the best chart of them all.

  Cramer agreed, saying he's bullish on all of these names.

• [By ]

  Cramer and Moreno also looked at General Dynamics (GD) which peaked in early March, before starting a downtrend until Tuesday. Last week, General Dynamics fell to the lower end of its channel, but then it bounced right to the high end, and Wednesday it firmly broke out above the high end of this channel. The stochastic oscillator, which is a powerful momentum indicator is making a bullish crossover, and based on today's move, Moreno thinks General Dynamics can return to its old highs at $230.

• [By Lou Whiteman]

  Two of the biggest laggards have been General Dynamics (NYSE:GD) and Huntington Ingalls (NYSE:HII), each down by more than 10% in the past three months. The similarities go well beyond stock performance. The companies have two of the more interesting outlooks for growth among defense players, but each seemed to catch investors off guard over how long it will take that increased business to materialize.

• [By Logan Wallace]

  These are some of the headlines that may have effected Accern’s analysis:

  Get General Dynamics alerts: U.S. Air Force Awards General Dynamics Cloud Services Contract (finance.yahoo.com) General Dynamics (GD) Receives Average Recommendation of “Buy” from Analysts (americanbankingnews.com) America Desperately Needs More Submarines. And That Is Good News for General Dynamics. (yahoo.com) GD completes Hawker Pacific acquisition (janes.com) General Dynamics Unit Secures Work for Aircraft Computer System Repairs, Replacement (govconwire.com)

  Shares of NYSE:GD traded up $3.17 on Tuesday, reaching $199.62. The company’s stock had a trading volume of 2,149,954 shares, compared to its average volume of 1,720,029. General Dynamics has a 52-week low of $190.30 and a 52-week high of $230.00. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.98 and a current ratio of 1.34. The stock has a market capitalization of $57.94 billion, a price-to-earnings ratio of 20.06, a PEG ratio of 1.89 and a beta of 0.84.

Traders Buy Shares of Altaba (AABA) on Weakness

Traders purchased shares of Altaba (NASDAQ:AABA) on weakness during trading on Friday. $145.58 million flowed into the stock on the tick-up and $20.10 million flowed out of the stock on the tick-down, for a money net flow of $125.48 million into the stock. Of all stocks tracked, Altaba had the 4th highest net in-flow for the day. Altaba traded down ($0.57) for the day and closed at $75.93

Several brokerages have weighed in on AABA. MKM Partners lifted their price objective on Altaba to $124.00 in a report on Friday. BidaskClub raised Altaba from a “hold” rating to a “buy” rating in a report on Friday, May 4th. ValuEngine raised Altaba from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd. Credit Suisse Group lifted their price objective on Altaba from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th. Finally, Oppenheimer lifted their price objective on Altaba from $98.00 to $104.00 and gave the company an “outperform” rating in a report on Wednesday, February 28th. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Altaba has a consensus rating of “Buy” and a consensus target price of $85.06.

Get Altaba alerts:

The firm has a market capitalization of $67.27 billion, a P/E ratio of 308.08 and a beta of 1.96.

In other news, CFO Alexi Wellman sold 1,262 shares of the business’s stock in a transaction on Monday, March 12th. The stock was sold at an average price of $76.90, for a total transaction of $97,047.80. Following the completion of the transaction, the chief financial officer now owns 16,643 shares of the company’s stock, valued at approximately $1,279,846.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 24.00% of the stock is currently owned by insiders.

A number of hedge funds have recently modified their holdings of AABA. Atria Investments LLC bought a new stake in Altaba during the 4th quarter worth $476,000. Westpac Banking Corp grew its position in Altaba by 41.8% during the 4th quarter. Westpac Banking Corp now owns 28,640 shares of the company’s stock worth $2,001,000 after acquiring an additional 8,440 shares during the last quarter. Syntal Capital Partners LLC bought a new stake in Altaba during the 4th quarter worth $1,460,000. Hollencrest Capital Management bought a new stake in Altaba during the 4th quarter worth $513,000. Finally, Personal Capital Advisors Corp bought a new stake in Altaba during the 4th quarter worth $287,000. Institutional investors and hedge funds own 73.34% of the company’s stock.

About Altaba

Altaba Inc operates as a non-diversified, closed-end management investment company in the United States. Its assets consist primarily of equity investments, short-term debt investments, and cash. The company was formerly known as Yahoo! Inc and changed its name to Altaba Inc in June 2017. Altaba Inc was founded in 1994 and is based in New York, New York.

Top 10 Bank Stocks To Invest In 2019

tags:TXN,SDRL,COG,ANIP,OXY,TXMD,MOSY,MDY,BGG,ICCC,

Investment company Quadrature Capital LTD buys The Priceline Group, Alibaba Group Holding, General Electric Co, Bank of Nova Scotia, Deere, Nucor, Canadian Imperial Bank of Commerce, Freeport-McMoRan, Visa, Salesforce.com, sells Cognizant Technology Solutions, FedEx, Allergan PLC, Charter Communications, Teva Pharmaceutical Industries during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Quadrature Capital LTD. As of 2016-12-31, Quadrature Capital LTD owns 588 stocks with a total value of $1.6 billion. These are the details of the buys and sells.

New Purchases: PCLN, BABA, GE, BNS, DE, NUE, V, CRM, MFC, MSFT, Added Positions: CM, FCX, SCHW, MGM, PFE, HAL, SYY, CLX, ULTA, HBI, Reduced Positions: TEVA, ESRX, LLY, AAPL, AXP, T, JBL, CAT, FB, DIS, Sold Out: CTSH, FDX, AGN, CHTR, UTX, HD, CVS, ATVI, LOW, EXPE,

For the details of Quadrature Capital LTD's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Quadrature+Capital+LTD

Top 10 Bank Stocks To Invest In 2019: Texas Instruments Incorporated(TXN)

Advisors' Opinion:

• [By Chris Lange]

  Texas Instruments Inc. (NASDAQ: TXN) is set to report its fourth-quarter results on Tuesday. The analysts�� consensus estimates are EPS of $1.09 and $3.74 billion in revenue. Shares were changing hands at $116.83 as last week came to a close. The consensus price target is $105.41, and the stock has a 52-week range of $74.16 to $119.98.

• [By Joseph Griffin]

  Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of Texas Instruments (NASDAQ:TXN) by 1.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,934,955 shares of the semiconductor company’s stock after purchasing an additional 39,041 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Texas Instruments were worth $304,912,000 at the end of the most recent reporting period.

• [By Lisa Levin]

  Some of the stocks that may grab investor focus today are:

  Wall Street expects Twitter, Inc. (NYSE: TWTR) to report quarterly earnings at $0.11 per share on revenue of $605.26 million before the opening bell. Twitter shares rose 0.16 percent to $30.52 in after-hours trading. Analysts expect Facebook, Inc. (NASDAQ: FB) to post quarterly earnings at $1.35 per share on revenue of $11.41 billion after the closing bell. Facebook shares gained 0.36 percent to $160.27 in after-hours trading. Before the markets open, Boeing Co (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion. Boeing shares rose 0.18 percent to $329.65 in after-hours trading. Texas Instruments Incorporated (NASDAQ: TXN) reported stronger-than-expected earnings for its first quarter on Tuesday. Texas Instruments shares climbed 5.62 percent to $103.95 in the after-hours trading session. Analysts are expecting Ford Motor Company (NYSE: F) to have earned $0.41 per share on revenue of $37.16 billion in the latest quarter. Ford will release earnings before the markets open. Ford shares gained 0.46 percent to $11.01 in after-hours trading. After the closing bell, PayPal Holdings, Inc. (NASDAQ: PYPL) is expected to post quarterly earnings at $0.54 per share on revenue of $3.59 billion. PayPal shares gained 0.16 percent to $75.40 in after-hours trading. Wall Street expects AT&T Inc. (NYSE: T) to post quarterly earnings at $0.88 per share on revenue of $39.29 billion after the closing bell. AT&T shares rose 0.20 percent to $35.07 in after-hours trading.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By ]

  But to the extent that investors are on edge about weakening demand, it's worth noting that earnings news flow has been encouraging for some parts of the industry. Here are some takeaways from the March quarter reports delivered so far by the likes of Texas Instruments (TXN) , STMicroelectronics (STM) , Taiwan Semiconductor (TSM) , Lam Research (LRCX) , Teradyne (TER) and SK Hynix (HXSCL) .

Top 10 Bank Stocks To Invest In 2019: Seadrill Limited(SDRL)

Advisors' Opinion:

• [By Money Morning News Team]

  (Nasdaq: CNET)

  $2.95 34.76% Seadrill Ltd. (NYSE: SDRL) $0.28 33.81% Intelsat Corp. (NYSE: I) $9.11 31.50% Navios Maritime Midstream Partners LP (NYE: NAP) $4.42 29.18% Limelight Networks Inc. (Nasdaq: LLNW) $4.89 28.61% Enphase Energy Inc. (Nasdaq: ENPH) $5.05 24.62%

  As you can see in the table above, penny stocks have the potential to provide tremendous returns for enterprising investors. However, it's important to note that investing in penny stocks is also incredibly risky.

• [By Lisa Levin]

  Wednesday afternoon, the energy shares climbed 1.59 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 77 percent, and EP Energy Corporation (NYSE: EPE), up 19 percent.

• [By Lisa Levin]

  Thursday afternoon, the energy shares rose 1.16 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 33 percent, and Ultra Petroleum Corp. (NYSE: UPL) up 14 percent.

• [By Lisa Levin]

  On Thursday, the energy shares rose 1.34 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 46 percent, and Sanchez Energy Corporation (NYSE: SN) up 8 percent.

Top 10 Bank Stocks To Invest In 2019: Cabot Oil & Gas Corporation(COG)

Advisors' Opinion:

• [By ]

  The hot list:

  Align Technology (ALGN) (+22% revenue growth estimate) Amazon (AMZN) (+22%) Autodesk (ADSK) (+27%) Cabot Oil & Gas (COG) (+34%) Concho Resources (CXO) (+30%) Facebook (FB) (+27%) Netflix (NFLX) (+25%) Pentair (PNR) (+22%) Vertex Pharmaceuticals (VRTX) (+22)

  "Firms with high revenue growth should outperform the S&P 500 during the next 12 months as the index climbs by 6% to our target of 2875," says Kostin. 

• [By ]

  Cabot Oil & Gas (NYSE: COG) has a strong position in the Marcellus Shale, a low-cost region for natural gas production that puts the company's break-even around $2.00 per mcf against spot prices around $2.80 per mcf. The company owns the rights to an additional 3,000 drilling locations within its undeveloped footprint which gives it the potential to increase output easily.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Cabot Oil & Gas (COG)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Bank Stocks To Invest In 2019: ANI Pharmaceuticals, Inc.(ANIP)

Advisors' Opinion:

• [By Joseph Griffin]

  Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

Top 10 Bank Stocks To Invest In 2019: Occidental Petroleum Corporation(OXY)

Advisors' Opinion:

• [By Chris Lange]

  Occidental Petroleum Corp.��s (NYSE: OXY) short interest increased to 11.05 million shares from the previous reading of 10.74 million. Shares recently traded at $83.20, in a 52-week range of $57.84 to $84.28.

• [By Chris Lange]

  Occidental Petroleum Corp.��s (NYSE: OXY) short interest increased to 10.74 million shares from the previous reading of 9.91 million. Shares recently traded at $76.60, in a 52-week range of $57.20 to $78.09.

• [By ]

  Already, shale companies such as Encana (ECA) , Occidental Petroleum (OXY) and Pioneer Natural Resources (PXD) , among others, are reporting higher cash flows and earnings on higher oil prices. As a result, they are paying down debt, increasing dividends and engaging in buybacks. This is a dramatic improvement in shareholder yield for the group.

• [By Chris Lange]

  Occidental Petroleum Corp.��s (NYSE: OXY) short interest decreased to 11.44 million shares from the previous reading of 11.77 million. Shares recently traded at $69.65, in a 52-week range of $57.20 to $78.09.

Top 10 Bank Stocks To Invest In 2019: TherapeuticsMD, Inc.(TXMD)

Advisors' Opinion:

• [By Ethan Ryder]

  TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

• [By ]

  TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical company with an exclusive focus on products for women and advanced hormone therapies. Biotech stocks are often a target for short sellers because of the uncertainty around drug development and approvals.

Top 10 Bank Stocks To Invest In 2019: MoSys, Inc.(MOSY)

Advisors' Opinion:

• [By Lisa Levin]

  MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

• [By Lisa Levin] Gainers MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast. The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance. Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results. Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome. RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics. ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings. ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results. Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings. Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Lisa Levin] Gainers The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance. WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast. Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39. Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results. ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings. Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million. Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results. Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results. VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71. Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results. Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results. Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results. Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739. Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
• [By Money Morning Staff Reports]

  That's why today we'll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

  Penny Stocks Current Share Price
  (as of Feb. 20) Feb. 12-20 Gain
  (as of Feb. 20) POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1% Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05% Intelsat SA (NYSE: I) $3.50 38.89% Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62% Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30% CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03% Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95% AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69% Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99% MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

  FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it's completely free…

Top 10 Bank Stocks To Invest In 2019: SPDR S&P MidCap 400 ETF (MDY)

Advisors' Opinion:

• [By ]

  Yet when it comes to investing, reward often comes from being willing to take on risk. Over the past 10 years, investors who've been willing to look at smaller companies have seen much stronger returns than those who've stuck with the tried-and-true big names that are more familiar to them. When you look at exchange-traded funds tracking indexes composed of companies of different sizes �� SPDR S&P 500 (NYSEMKT: SPY) for large companies, SPDR S&P Midcap 400 (NYSEMKT: MDY) for midsize companies and SPDR S&P SmallCap 600 (NYSEMKT: SLY) for small companies �� you can put a number on just how much better smaller stocks have done:

• [By Dan Caplinger]

  Yet when it comes to investing, reward often comes from being willing to take on risk. Over the past 10 years, investors who've been willing to look at smaller companies have seen much stronger returns than those who've stuck with the tried-and-true big names that are more familiar to them. When you look at exchange-traded funds tracking indexes composed of companies of different sizes -- SPDR S&P 500 (NYSEMKT:SPY) for large companies, SPDR S&P Midcap 400 (NYSEMKT:MDY) for midsize companies, and SPDR S&P SmallCap 600 (NYSEMKT:SLY) for small companies -- you can put a number on just how much better smaller stocks have done:

Top 10 Bank Stocks To Invest In 2019: Briggs & Stratton Corporation(BGG)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Check-Cap Ltd. (NASDAQ: CHEK) fell 23.3 percent to $9.87 in pre-market trading after declining 13.45 percent on Wednesday. SunCoke Energy Partners, L.P. (NYSE: SXCP) fell 12.8 percent to $16.00 in pre-market trading after reporting Q1 results. Briggs & Stratton Corporation (NYSE: BGG) fell 11 percent to $17.55 in pre-market trading after the company posted mixed Q3 results and lowered its FY18 guidance. New Gold Inc. (NYSE: NGD) fell 8.4 percent to $2.30 in pre-market trading following downbeat Q1 results. Quality Care Properties, Inc. (NYSE: QCP) fell 8.2 percent to $20.85 in pre-market trading. Welltower announced plans to acquire QCP for $20.75 per share in cash. China Customer Relations Centers Inc. (NASDAQ: CCRC) shares fell 7.5 percent to $17.25 in pre-market trading after climbing 18.73 percent on Wednesday. Nokia Corporation (NYSE: NOK) shares fell 5.7 percent to $5.58 in pre-market trading after reporting Q1 results. eBay Inc. (NASDAQ: EBAY) fell 5.6 percent to $38.66 in pre-market trading following Q1 results. Southw
• [By ]

  For his "Executive Decision" segment, Cramer spoke with Todd Teske, chairman, president and CEO of Briggs & Stratton (BGG) , the small-engine maker that posted a penny-a-share earnings beat on Wednesday, but saw shares fall 11% on lighter-than-expected revenues and a cut in the company's full-year guidance.

Top 10 Bank Stocks To Invest In 2019: ImmuCell Corporation(ICCC)

Advisors' Opinion:

• [By Stephan Byrd]

  ImmuCell (NASDAQ:ICCC) released its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, Bloomberg Earnings reports. ImmuCell had a negative net margin of 1.61% and a negative return on equity of 0.79%.